Summary
In order to clarify the question of whether the modulatory effects of cations on dopamine receptor affinities are brought about by shifts in the equilibrium of receptor — G-protein — coupling, it was investigated whether mono- and divalent cations were still able to modulate rat striatal D1 and D2 receptor affinities after selective inactivation of the G-proteins linked to the two receptors. The GS-protein coupled to the D1 receptor was eliminated by mild thermal inactivation, and the Gi- (or Go-) protein associated with the D2 receptor by alkylation with a low concentration of N-ethyl-maleimide. Incubation of striatal membranes at 60°C completely abolished the specific binding of3H-GTP. Both treatments resulted in an increase of the IC50-values for dopamine as a displacer of3H-SCH 23390 from D1- and of3H-spiperone from D2 receptors. Concomitantly, the formerly shallow D1 displacement curves became steeper, with their Hill coefficients increasing. This effect was less evident at D2 receptors. Guanosine triphosphate (GTP), which increased the IC50's of dopamine for both receptors approximately two-fold in control membranes, was without effect in pretreated samples, indicating an effective inactivation of the G-proteins. Na+ ions were still able to lower, and Ca2+ ions to increase the affinities of D1 and D2 receptors for dopamine after such inactivation of the respective G-proteins. It is concluded that the mechanism underlying the regulation of dopamine receptor affinities by mono- and divalent cations is independent of and superimposed upon the coupling of these receptors to guanyl nucleotide binding proteins.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
Analysis of variance; G-proteins, guanyl nucleotide binding proteins (Gs: stimulatory, Gi: inhibitory);
- GTP:
-
guanosine-5′-triphosphate; Gpp(NH)p, 5′-guanylylimidodiphos-phate;
- NEM:
-
N-ethyl-maleimide
References
Abramson SN, McGonigle P, Molinoff PB (1987) Evaluation of models for analysis of radioligand binding data. Mol Pharmacol 31:103–111
Asano T, Ogasawara N (1986) Uncoupling of γ-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: Effect of N-ethylmaleimide on purified GTP-binding proteins. Mol Pharmacol 29:244–249
Avissar S, Schreiber G, Danon A, Belmaker RH (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440–442
De Keyser J, De Backer J-P, Convents A, Ebinger G, Vauquelin G (1985) D2 dopamine receptors in calf globus pallidus: agonist high- and low affinity sites not regulated by guanine nucleotide. J Neurochem 45:977–979
De Lean A, Stadel JM, Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase coupled \-adrenergic receptor. J Biol Chem 255:7108–7117
De Vries DJ, Beart P (1985) Magnesium ions reveal nanomolar potency of dopamine at3H-spiperone labelled D2 receptors in rat corpus striatum. Eur J Pharmacol 109:417–419
Dumbrille-Ross A, Seeman P (1987) Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary. Biochem Pharmacol 36:2095–2099
Grigoriadis D, Seeman P (1986)3H-Domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 332:21–25
Hamblin MW, Creese I (1982a)3H-dopamine binding to rat striatal D2 and D3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. Life Sci 30:1587–1595
Hamblin MW, Creese I (1982b) Heat treatment mimics Guanosine5′-triphosphate effects on dopaminergic3H-ligand binding to bovine caudate membranes. Mol Pharmacol 21:52–56
Hamblin MW, Leff SE, Creese I (1984) Interactions of agonists with D2 dopamine receptors: Evidence for a single receptor population existing in multiple agonist affinity states in rat striatal membranes. Biochem Pharmacol 33:877–887
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Kilpatrick BF, Caron MG (1983) Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors. J Biol Chem 258:13528–13534
Kilpatrick BF, De Lean A, Caron MG (1982) Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides. Mol Pharmacol 22:298–303
Lee TWT, Sole MJ, Wells JW (1986) Assessment of a ternary model for the binding of agonists to neurchumoral receptors. Biochemistry 25:7005–7020
Limbird LE, Speck JL (1983) N-Ethylmaleimide, elevated temperature, and digitonin solubilization eliminate guanine nucleotide but not sodium effects on human platelet α2-adrenergic receptor-agonist interactions. J Cyclic Nucleotide Protein Phosphorylation Res 9:191–202
Makman MH, Dvorkin B, Klein PN (1982) Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina. Proc Natl Acad Sci [USA] 79:4212–4216
Minuth M, Jakobs KH (1986) Sodium regulation of agonist and antagonist binding to \-adrenoceptors in intact and Ns-deficient membranes. Naunyn-Schmiedeberg's Arch Pharmacol 333:124–129
Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P (1986) Dopamine D1 receptors characterized with3H-SCH 23390. Solubilization of a guanine nucleotide sensitive form of the receptor. J Biol Chem 261:8397–8406
Ohara K, Haga K, Berstein G, Haga T, Ichiyama A, Ohara K (1988) The interaction between D2 dopamine receptors and GTP-binding proteins. Mol Pharmacol 33:290–296
Onali P, Olianas M, Gessa GL (1984) Selective blockade of dopamine D1 receptors by SCH 23390 discloses striatal dopamine receptors mediating the inhibition of adenylate cyclase in rats. Eur J Pharmacol 99:127–128
Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Seeman P, Ulpian C, Grigoriadis D, Pri-Bar I, Buchman O (1985) Conversion of dopamine D1 receptors from high to low affinity for dopamine. Biochem Pharmacol 34:151–154
Senogles SE, Benovic JL, Amlaiky N, Unson C, Milligan G, Vinitsky R, Spiegel AM, Caron MG (1987) The D2 dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein. J Biol Chem 262:4860–4867
Sibley DR, De Lean A, Creese I (1982) Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D2 dopamine receptor. J Biol Chem. 257:6351–6361
Simmonds SH, Strange PG (1985) Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells. Neurosci Lett 60:267–272
Stoof JC, Kebabian JW (1981) Opposing roles for D1 and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366–368
Urwyler S (1987) Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors. J Neurochem 49:1415–1420
Urwyler S, Coward D (1987) Binding of3H-spiperone and3H-(−)-sulpiride to dopamine D2 receptors in rat striatal membranes: Methodological considerations and demonstration of the identical nature of the binding sites for the two ligands. NaunynSchmiedeberg's Arch Pharmacol 335:115–122
Urwyler S, Markstein R (1986) Identification of dopamine “D3” and “D4” binding sites, labelled with3H-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. J Neurochem 46:1058–1067
Wreggett KA (1987) Alkylation of the bovine anterior pituitary D2 dopamine receptor: inconsistency with predictions of the ternary complex model. Biochem Biophys Res Comm 147: 1070–1076
Wreggett KA, De Lean A (1984) The ternary complex model. Its properties and application to ligand interactions with the D2 dopamine receptor of the anterior pituitary gland. Mol Pharmacol 26:214–227
Wreggett KA, Seeman P (1984) Agonist high- and low-affinity states of the D2 dopamine receptor in calf brain. Partial conversion by guanine nucleotide. Mol Pharmacol 25:10–17
Zimmerman U-JP, Schlaepfer WW (1984) Calcium-activated neutral protease (CANP) in brain and other tissues. Progr Neurobiol 23: 63–78
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Urwyler, S. Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins. Naunyn-Schmiedeberg's Arch. Pharmacol. 339, 374–382 (1989). https://doi.org/10.1007/BF00736050
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00736050